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Abstract    1 
Objective:  To characterize a novel family with non-progressive pure spinocerebellar ataxia (SCA) 2 
caused by a deletion in the inositol 1, 4, 5-triphosphate receptor 1 (ITPR1) gene on chromosome 3.  3 
This is the first detailed clinical, genetic and radiological description of this genotype. 4 
Background:  Deletions in the ITPR1 gene have been shown to cause SCA15 and SCA16 in four 5 
families to date.  A further Japanese family has been identified with an ITPR1 point mutation.  The exact 6 
prevalence is unknown as only around 30 families have been screened worldwide. 7 
Methods:   The clinical phenotype of the family is described and videotaped clinical examinations 8 
presented.  Serial brain MRIs were carried out on one affected individual and genetic analysis performed 9 
on all family members.  Protein analysis confirmed the ITPR1 deletion.   10 
Results:  Affected subjects display a remarkably slow pure cerebellar syndrome.  Serial MRIs 11 
show progressive midline cerebellar atrophy with mild inferior parietal and temporal cortical 12 
volume loss.  Genetic analysis shows a deletion of 346.487Kb in the ITPR1 gene (the largest 13 
ITPR1 deletion reported to date), suggesting SCA15 is due to a loss of ITPR1 function.  Western 14 
blotting of lymphoblastoid cell line protein confirms reduced ITPR1 protein levels. 15 
Conclusions:  SCA15 is a slowly or non-progressive pure cerebellar ataxia which appears to be caused 16 
by a loss of ITPR1 function and a reduction in the translated protein. This family highlights the disparity 17 
between progressive cerebellar atrophy on MRI and absent clinical progression, and suggests that 18 
patients with non-progressive or slowly progressive ataxia should be screened for ITPR1 defects. 19 
 20 
Keywords:  All clinical neurology [14], Genetic linkage [94], MRI [120], Spinocerebellar ataxia [298], 21 
Cerebellum [312]   22 
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According to Harding’s classification (1), the autosomal dominant spinocerebellar ataxias 3 
(ADCAs) can be subdivided clinically into three groups:  ADCA type I – ataxia associated with 4 
extracerebellar symptoms; type II – ataxia associated with pigmentary retinopathy and type III - 5 
pure cerebellar ataxia.  ADCAIII, pure spinocerebellar ataxia, is by far the commonest type of 6 
ataxia seen (2, 3). 7 
 8 
Spinocerebellar ataxia 15 (SCA15) was first described by Storey et al in 2001 (2). They reported an 9 
Australian kindred with slowly or non-progressive ataxia, slurred speech, dysphagia, disrupted eye 10 
movements and slightly brisk knee jerks.  Some affected members of the family also had a tremor.  11 
Linkage analysis located the SCA15 locus in an 11.6-cM region on 3p24.2-3pter, a region which 12 
was noted to contain the ITPR1 gene.  The genetic defects in two Japanese families with ADCAIII 13 
were found to overlap this linked region on 3p25.3-26.1 (4).  A further Australian family was 14 
identified with a similar phenotype of non-progressive ataxia (5) linked to a region of chromosome 15 
3 overlapping the original SCA15 locus; though in this family, affected members also had cognitive 16 
impairment.   17 
 18 
Mouse models with ITPR1 deletions have a phenotype of ataxia and epilepsy in homozygous 19 
animals (6).  In 2007, van de Leemput et al (7) identified an ataxic mouse with a small ITPR1 20 
deletion and in light of this, revisited the genetic analysis of the original Australian SCA15 family 21 
and two additional UK families with a similar phenotype.  A deletion involving both the 5’ region 22 
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of the ITPR1 gene and the 3’ region of the SUMF1 genes was identified in the affected members of 1 
all three families. 2 
 3 
In addition, the two original and one further Japanese family with a similar phenotype (originally classed 4 
as having SCA16) were shown to have ITPR1 defects (8, 9).  Of the two original Japanese families, an 5 
ITPR1 deletion was seen in affected members of one kindred and an ITPR1 point mutation in the other, 6 
confirming the pathogenicity of the ITPR1 gene and conclusively ruling out the role of SUMF1.   In 7 
2008, Gardner proposed that SCA15 and SCA16 are in fact the same condition:  an ITPR1-associated 8 
ataxia (3). 9 
 10 
We describe the clinical and genetic findings in a previously unreported UK family with a very 11 
slowly progressive pure cerebellar ataxia.  All affected subjects have a deletion in the ITPR1 gene.  12 
Serial MRI brain scans were carried out to delineate the rate of cerebellar atrophy in comparison to 13 
clinical features.  Immunoblotting of lymphocytes from one affected individual showed a reduction 14 




Materials and Methods 19 
Subjects.  Ethical approval to investigate spinocerebellar ataxias was obtained from the local 20 
ION/NHNN ethical committee. Our index subject was identified through the Neurogenetics Clinic at the 21 
NHNN and her brother, uncle and two cousins were contacted through her.  A family tree, consistent 22 
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with autosomal dominant inheritance, is shown (figure 1).  All subjects gave a clinical history, 1 
underwent a clinical examination including SARA score and gave a blood sample for genetic analysis.  2 
The three affected subjects agreed to their clinical examination being videotaped. All subjects gave 3 
informed consent for this study. 4 
 5 
Genetics.  High density genome-wide genotyping was performed by using the Affymetrix SNP6.0 6 
DNA array which has more than 906,600 single nucleotide polymorphisms (SNPs).  500ng of DNA 7 
from the proband was analysed according to the manufacturer’s instructions by using the Whole 8 
Genome Sampling Assay (Kennedy GC 2003).  Restriction digestion of 250ng fractions of each 9 
DNA sample was performed using NspI and StyI.  The digested DNA was then ligated with 10 
adaptors, and the adaptor-ligated DNA amplified with a single primer complementary to the 11 
adaptor.  The polymerase chain reaction (PCR) products were pooled, fragmented and end-labelled 12 
using biotinylated nucleotides.  The labelled product was then hybridised to a SNP6.0 array, 13 
washed and stained in the fluidics station, and then detected with the GCS3000 scanner. 14 
 15 
The large ITPR1 deletion was identified from the SNP6.0 array data.  This deletion occurred over 16 
the SUMF1 gene and the ITPR1 gene, removing exons 1-3 of SUMF1 and exons 1-48 of ITPR1 17 
(figure 2b).  To identify the flanking regions of the deletion, we designed primers to PCR and 18 
amplify over the deletion in affected individuals.  The PCR would not work in unaffected 19 
individuals or controls because of the large size of the deletion, so we added in an internal positive 20 
control to test for PCR amplification; this control consisted of primers to a known fragment of the 21 
BDNF gene (figure 2a).  PCR was carried out using 10pmol of both forward and reverse genomic 22 
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primers for the SCA15 genomic deletion and the BDNF gene (both primers in the same reaction) 1 
and FastStart Taq DNA polymerase (www.roche-applied-science.com).  Each purified product was 2 
then sequenced using forward or reverse SCA15 genomic primers with Applied Biosystems 3 
BigDye terminator v3.1 sequencing chemistry as per the manufacturer’s instructions; the resulting 4 
reactions were resolved on an ABI3730XL genetic analyzer (Applied Biosystems, Foster city, CA) 5 
and analyzed with Sequencher 4.8 software (Gene Codes Corporation, Ann Arbor, MI).  The 6 
primers that were used were: SCA15 genomic forward 5’-tcaagagatatgtcaccatac-3’; SCA15 reverse 7 
5’-gtccatttaaaccacacac-3’; BDNF forward 5’-aaagaagcaaacatccgaggacaag- 3’; and BDNF reverse 8 
5’-attcctccagcagaaagagaagagg-3’.  The BDNF fragment was 276 bp, and the SCA15 fragment 9 
amplified over the deletion was 247 bp (figure 2).   10 
 11 
Cell culture and preparation.  Lymphoblastoid cell lines were created by isolating immature blood 12 
lymphoblasts and immortalizing them with Epstein-Barr virus.  Lymphoblasts were cultured in a T75 13 
flask in RPMI-1640 media (Sigma) containing 15% Fetal Bovine Serum (GIBCO) and 2mM L- 14 
Glutamine (GIBCO), and were fed every two days.   After collection, the cells were pelleted by being 15 
centrifuged at 200g.  The pellet was then resuspended in PBS (Sigma) containing protease inhibitor 16 
cocktail (Roche), then centrifuged again.  The supernatant was discarded and the pelleted cells were 17 
stored at -80°C until further use.   18 
 19 
Western blot.  The cells were lysed in 50mM Tris (pH 8.0) containing 150mM NaCl, 0.5% Triton X-20 
100, 0.5% sodium deoxycholate and protease inhibitors.  Benzonase was added (50U/ml final 21 
concentration) and the cells were incubated on ice for fifteen minutes.  Protein concentrations were 22 
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determined by BCA and adjusted to 1mg/ml.  Gel samples were prepared by the addition of 5X sample 1 
buffer (0.625M Tris-HCl, pH 6.8, 50% glycerol, 10% (w/v) SDS, a trace of bromophenol blue and 10% 2 
-mercaptoethanol) and heating at 95°C for five minutes.  The proteins were then separated on 6% SDS 3 
gels and transferred to PVDF.  Membranes were blocked with PBS/0.1% Tween 20 (PBS-T) containing 4 
10% dried milk powder for 30 minutes, washed briefly in PBS-T and then incubated overnight at 4°C on 5 
a shaker with primary antibody diluted in PBS-T.  This solution contained 1% BSA for anti-ITPR1, 6 
(Chemicon anti-IP3 receptor 1, diluted 1:2000) or 1% dried milk powder  for anti-actin (clone AC15, 7 
Sigma diluted 1:10,000).  The membranes were washed five times in PBS-T then incubated at room 8 
temperature for 60 minutes with secondary antibody HRP conjugates diluted in PBS-T which contained 9 
1% dried milk powder. They were then washed in PBS-T a further five times and developed with ECL 10 
reagents.   11 
   12 
Imaging.  A 3T MRI scan (Siemans TIM Trio) was performed on one affected individual (subject 2) and 13 
T1 weighted images were obtained (figure 3b).  These images were compared with a 1.5T MRI scan 14 
(GE Sigma Horizon LX Echospeed Plus) obtained five years earlier (figure 3a). 15 
 16 
Results 17 
Clinical characteristics:  case histories of affected subjects 18 
Subject 1 (proband) is 40 years old.  She attained normal motor milestones, but describes herself as 19 
having been clumsy and bad at sport at school.  During her 20s, she developed mild unsteadiness when 20 
walking.  This has slowly progressed since, but she remains independently ambulant.  She has mild 21 
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slurring of her speech, which is more pronounced when she is tired.  She intermittently notices that her 1 
eye movements are jerky, and, again, this is more marked when she is tired. 2 
 3 
Subject 2 is 38 years old.  He also attained normal motor milestones but was poor at sports at school, 4 
with particular problems balancing when trying to do gymnastics.  He notes that he has been prone to 5 
falling over for as long as he can remember.  His balance deteriorated from his teens, and during his late 6 
20s, he noticed that his speech became slurred when he was tired.  In his early 30s, his limb coordination 7 
and eye movements became jerky and he began to experience intermittent involuntary limb jerking 8 
(myoclonus).  Around this time, he had an acute episode of hearing loss, vertigo, nausea and vomiting 9 
which was diagnosed as viral labyrinthitis.  The acute symptoms resolved, but his balance deteriorated 10 
and never returned to its former level.  He currently has mild gait ataxia.    11 
 12 
Subject 3 is 56 years old.  Since his teens, he was aware that he was unable to carry drinks from the bar 13 
without spilling them.  He attributed this to difficulties with both walking and coordinating his hands.  14 
His brother was diagnosed with ataxia during subject 3’s mid-30s, prompting him to try some clinical 15 
assessment tests.  Rapid finger tapping and heel-shin coordination were impaired.  He became more 16 
aware of his symptoms when his wife died when he was 38 years old, and his ataxic gait became more 17 
noticeable.  He has never noticed his dysarthria himself, but other people have commented on it since 18 
his early 50s.  He has a slightly slow, broad-based gait, but is able to walk for unlimited distances.  He 19 
has minimal functional impairment:  he works as a carer, though he avoids lifting clients as he is aware 20 
that his balance is impaired. 21 
 22 
Novak, page 10 
 
ITPR1 gene deletion causes SCA15 and 16:  a description of the phenotype 
 
Clinical characteristics:  clinical examination.  All three affected subjects show signs consistent with a 1 
cerebellar syndrome; namely ataxia, cerebellar dysarthria and abnormal eye movements.  These findings 2 
are detailed in table 1.  (SARA scores are given in supplement 2). In addition subject 3 had 3 
hyperreflexia.  Subjects had full power in their limbs and normal sensation.  There was no evidence of 4 
retinal disease and no cognitive dysfunction.   5 
Subjects 4 (male; 27 years old) and 5 (male; 22 years old) were asymptomatic and had normal clinical 6 
examinations. 7 
 8 
Imaging.  The initial 1.5T MRI of subject 2 (figure 3a) showed midline superior and inferior cerebellar 9 
atrophy and mild posterior parietal and temporal volume loss.  Brainstem structures were preserved.  10 
The follow-up 3T MRI (figure 3b) showed progression of the midline cerebellar atrophy, with the 11 
atrophy more marked superiorly than inferiorally.  The mild cortical volume loss had not progressed.   12 
 13 
Genetics.  A large deletion (346.487Kb) including exons 1-3 of the SUMF1 and exons 1-48 of the 14 
ITPR1 gene in the 5’ region of ITPR1 was identified in all affected individuals (figure 2b).  This ITPR1 15 
deletion is the largest reported to date, and segregates with pure ataxia in this ADCAIII family.  It is not 16 
present in 100 UK controls.  The location of the deletion, removing the first 48 exons, suggests that the 17 
function of the ITPR1 gene will be lost in the mutated allele.  Analysis of lymphoblastoid derived 18 
protein on a western blot indicates that the ITPR1 translated protein is reduced compared with a control 19 
(figure 4), confirming the postulated genetic mechanism of loss of function and haploinsufficiency. 20 
 21 
 22 
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Discussion 1 
These results illustrate the clinical, radiological and genetic features of the SCA15 phenotype. 2 
Genetic analysis confirmed a deletion in the ITPR1 gene in all affected subjects; this segregated 3 
with the disease and was absent in all clinically unaffected individuals. 4 
 5 
Affected members of this family display a slowly progressive, or non-progressive, relatively pure 6 
cerebellar syndrome, with the onset of symptoms in early adulthood.  This pattern is in keeping with 7 
previous reports of SCA15 (2, 7).  Hyperreflexia, as seen in subject 3 (our subject with the longest 8 
duration of symptoms), was also described in some members of the original Australian SCA15 family 9 
(2) and of the Japanese SCA15 (4) and SCA16 (10) families .  Normal life spans have been achieved by 10 
most deceased symptomatic members of our family in the past, strengthening the current consensus that 11 
SCA15 does not shorten life expectancy. Serial MRI brain scans have not previously been reported in 12 
SCA15 patients, and it is notable that the progression in cerebellar atrophy seen on subject 2’s MRI was 13 
visible over a five year period during which no clinical progression was detected by patient or clinician.  14 
This finding may prove relevent in the development of biomarkers for disease-modifying drug trials in 15 
the future.  The mild volume loss seen in the parietal and temporal lobes is also interesting; cortical 16 
atrophy has not been observed in previous SCA15 imaging.   17 
 18 
As expected, the almost complete deletion of the ITPR1 gene leads to a loss of mRNA transcription 19 
and reduced ITPR1 protein (seen on western blotting).  The main function of the ITPR1 gene is to 20 
mediate the release of intracellular stores of calcium from the endoplasmic reticulum by playing a 21 
key role in the inositol messenger pathway.  The ITPR1 gene is highly expressed in the cerebellum 22 
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in Purkinje cells and other neurons.  The slow degeneration of these cells may therefore be due to a 1 
particular sensitivity to calcium homeostasis.  The inositol triphosphate (IP3) pathway is also 2 
critical to calcium homeostasis, and this is reflected in the six spontaneously ataxic mouse models 3 
of genes involved in this cascade that have been identified to date.  Mutant mice in this and 4 
associated pathways include Grm1 (11), Gnaq (12), Plcb4 (13), Itpr1 (6), Car8 (14), and Inpp4 5 
(15). 6 
 7 
Overall, our data extends the phenotype of ITPR1-associated ataxia, or SCA15, and confirms that 8 
ITPR1 deletion leads to loss of function in the translated protein.  The phenotype and potential 9 
frequency of ITPR1 genetic defects suggests that this genetic test should be a routine DNA screen 10 
available in all neurogenetic clinics. 11 
 12 
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Figure Legends 1 
Figure 1 Family tree showing autosomal dominant pattern of inheritance. 2 
Figure 2a PCR across the deleted region.  The positive control primers (BDNF; 276bp, 3 
upper band) amplify in each reaction in all cases.  The SCA15 primers (247bp, lower band) only 4 
amplify when the large SCA15 deletion is present.  In this assay, therefore, affected subjects 5 
have two bands and unaffected subjects have just one.   6 
Figure 2b Sequencing across the deleted region reveals the size of the deletion. 7 
Figure 3a Initial MRI scan of subject 2.  showed midline superior and inferior cerebellar 8 
atrophy and mild posterior parietal and temporal volume loss.  Brainstem structures were 9 
preserved.  The follow-up 3T MRI (figure 3b) showed progression of the midline cerebellar 10 
atrophy, with the atrophy more marked superiorly than inferiorally.  The mild cortical volume 11 
loss had not progressed.   12 
Figure 3b Follow-up MRI scan of subject 2 (carried out five years after the initial scan). 13 
Figure 4 Western blot showing reduced levels of ITPR1-translated protein in SCA15 14 
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Age (years) 40 38 56 
Sex Female Male Male 
Gait and 
stance 
Mild impairment of 
tandem walking; 
unable to stand in 
tandem position. 
Mild impairment of 
tandem walking; 
unable to stand in 
tandem position. 
Slowed walking with mild 
broad-based gait; marked 
impairment of tandem 
walking.  Unsteady when 
standing with feet 
together. 
Sitting Normal Normal Normal 
Speech 
disturbance 





Mild dysmetria with 
low amplitude 
tremor 

















Mildly jerky pursuit 
with one-two beats 
fine nystagmus in 
all directions. 
Smooth pursuit with 
one-two beats 
nystagmus in all 
directions. 
Jerky horizontal pursuit 
with one-two beats 




Hypermetria Jerky horizontal 
saccades 
Slightly slow initiation.  
Marked hypermetria 
Reflexes Normal Normal Hyperreflexia 
Tone Normal Normal Increased 
 2 
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